NASDAQ
No price data available for this timeframe.
Aclaris Therapeutics, Inc. (ACRS) has a eps (basic) of $-0.53 as of Wednesday, December 31, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.